通过调节CREB1表达,SLC35F2促进NSCLC的进展
1Department of Laboratory Diagnosis, Heilongjiang Provincial Hospital, 82 Zhongshan Road, Xiangfang District, Harbin, 150036 China.
Cytotechnology
|July 16, 2025
概括
溶性载体家族35成员F2 (SLC35F2) 通过抑制cAMP/CREB1通路驱动非小细胞肺癌 (NSCLC) 的进展. 减少SLC35F2可能为NSCLC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症信号传递 癌症信号传递
背景情况:
- 溶性载体家族35成员F2 (SLC35F2) 被认为是非小细胞肺癌 (NSCLC) 的致癌驱动因素.
- 通过SLC35F2影响NSCLC进展的确切机制尚不清楚.
- 了解SLC35F2的作用对于开发向疗法至关重要.
研究的目的:
- 研究SLC35F2在非小细胞肺癌 (NSCLC) 进展中的机制性作用.
- 探索cAMP信号通路在SLC35F2介导NSCLC中的参与.
- 评估SLC35F2作为NSCLC的潜在治疗点.
主要方法:
- 对TCGA和GEPIA数据库进行SLC35F2表达和与预后相关性的生物信息分析.
- 功能丰富分析以识别改变的路径,包括cAMP信号.
- 实验验证使用RT-qPCR,Western blot和各种基于细胞的测定 (CCK-8,EDU,殖民地形成,流细胞计,TUNEL,scratch,Transwell) 进行SLC35F2敲击后的实验验证.
- 对cAMP/CREB1信号轴的研究.
主要成果:
- 在NSCLC组织中,SLC35F2表达显著升高,与患者预后不佳相关.
- 高SLC35F2水平与cAMP信号通路的改变有关.
- 击败SLC35F2抑制了NSCLC细胞的增殖,迁移和入侵,同时促进了细胞亡.
- 抑制SLC35F2通过上调CREB1.1激活了cAMP信号通路.
结论:
- 通过负调节cAMP/CREB1信号轴,SLC35F2促进NSCLC的进展.
- 向SLC35F2为非小细胞肺癌提供了一个有前途的治疗策略.
- 对SLC35F2/cAMP/CREB1通路的进一步研究可能会为NSCLC提供新的治疗方法.
相关概念视频
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


